Literature DB >> 7870874

Effects of repeated mild stress and two antidepressant treatments on the behavioral response to 5HT1C receptor activation in rats.

J L Moreau1, F Jenck, J R Martin, S Perrin, W E Haefely.   

Abstract

This study investigated the possible involvement of 5HT1C receptors in the development of depressive states and in the mode of action of antidepressants. The effects of repeated unpredictable mild stress (a regimen known to induce an anhedonic state in the rat) and of chronic administration of either of two recognized antidepressant treatments (sleep deprivation or inhibition of monoamine oxidase type A) in rats were studied on a 5HT1C receptor initiated response, i.e. mCPP-induced penile erection. A 3-week period of repeated, but unpredictable exposure to mild stressors induced a shift to the left of the dose-response curve for mCPP-induced penile erection. In contrast, 72-h REM sleep deprivation resulted in a shift to the right of the mCPP dose-response curve and 10-day administration of the monoamine oxidase type A inhibitor moclobemide (20 mg/kg IP bid) also resulted in a decreased number of mCPP-induced penile erections. These findings support the hypothesis that neuronal activities initiated via 5HT1C receptor stimulation may play a role in the pathophysiology and treatment of depression.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7870874     DOI: 10.1007/bf02246963

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  26 in total

1.  An animal model of anhedonia: attenuation of sucrose consumption and place preference conditioning by chronic unpredictable mild stress.

Authors:  M Papp; P Willner; R Muscat
Journal:  Psychopharmacology (Berl)       Date:  1991       Impact factor: 4.530

2.  Restraint stress-induced changes in saccharin preference: the effect of antidepressive treatment and diazepam.

Authors:  A Płaźnik; R Stefański; W Kostowski
Journal:  Pharmacol Biochem Behav       Date:  1989-08       Impact factor: 3.533

3.  Abnormalities of indoleamines in affective disorders.

Authors:  A Coppen; A J Prange; P C Whybrow; R Noguera
Journal:  Arch Gen Psychiatry       Date:  1972-05

4.  Long-term antidepressant treatment decreases spiroperidol-labeled serotonin receptor binding.

Authors:  S J Peroutka; S H Snyder
Journal:  Science       Date:  1980-10-03       Impact factor: 47.728

5.  REM-sleep deprivation, stress and emotional behavior in rats.

Authors:  V M Kovalzon; V L Tsibulsky
Journal:  Behav Brain Res       Date:  1984-12       Impact factor: 3.332

6.  A cross-sectional study of the effects of depression on REM latency.

Authors:  D E Giles; H P Roffwarg; A J Rush
Journal:  Biol Psychiatry       Date:  1990-10-15       Impact factor: 13.382

Review 7.  A role for 5-HT in the action of antidepressant drugs.

Authors:  P J Cowen
Journal:  Pharmacol Ther       Date:  1990       Impact factor: 12.310

8.  Chronic but not acute antidepressants interfere with serotonin (5-HT1B) receptors.

Authors:  H Frances; F Khidichian
Journal:  Eur J Pharmacol       Date:  1990-04-10       Impact factor: 4.432

9.  Evidence for REM sleep deprivation as the mechanism of action of antidepressant drugs.

Authors:  G W Vogel
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  1983       Impact factor: 5.067

10.  Attenuation of 5-HT1A and 5-HT2 but not 5-HT1C receptor mediated behaviour in rats following chronic treatment with 5-HT receptor agonists, antagonists or anti-depressants.

Authors:  H H Berendsen; C L Broekkamp
Journal:  Psychopharmacology (Berl)       Date:  1991       Impact factor: 4.530

View more
  6 in total

1.  Dysregulation of diurnal rhythms of serotonin 5-HT2C and corticosteroid receptor gene expression in the hippocampus with food restriction and glucocorticoids.

Authors:  M C Holmes; K L French; J R Seckl
Journal:  J Neurosci       Date:  1997-06-01       Impact factor: 6.167

2.  Astroglial Serotonin Receptors as the Central Target of Classic Antidepressants.

Authors:  Alexei Verkhratsky; Vladimir Parpura; Caterina Scuderi; Baoman Li
Journal:  Adv Neurobiol       Date:  2021

Review 3.  Innovative approaches for the development of antidepressant drugs: current and future strategies.

Authors:  Lee E Schechter; Robert H Ring; Chad E Beyer; Zoë A Hughes; Xavier Khawaja; Jessica E Malberg; Sharon Rosenzweig-Lipson
Journal:  NeuroRx       Date:  2005-10

4.  S32006, a novel 5-HT2C receptor antagonist displaying broad-based antidepressant and anxiolytic properties in rodent models.

Authors:  Anne Dekeyne; Clotilde Mannoury la Cour; Alain Gobert; Mauricette Brocco; Françoise Lejeune; Florence Serres; Trevor Sharp; Annie Daszuta; Amélie Soumier; Mariusz Papp; Jean-Michel Rivet; Gunnar Flik; Thomas I Cremers; Olivier Muller; Gilbert Lavielle; Mark J Millan
Journal:  Psychopharmacology (Berl)       Date:  2008-06-04       Impact factor: 4.530

5.  Antidepressant-like effects of the novel, selective, 5-HT2C receptor agonist WAY-163909 in rodents.

Authors:  Sharon Rosenzweig-Lipson; Annmarie Sabb; Gary Stack; Paul Mitchell; Irwin Lucki; Jessica E Malberg; Steve Grauer; Julie Brennan; John F Cryan; Stacey J Sukoff Rizzo; John Dunlop; James E Barrett; Karen L Marquis
Journal:  Psychopharmacology (Berl)       Date:  2007-02-13       Impact factor: 4.415

6.  Protective Effect of Lactobacillus rhamnosus GG on TiO2 Nanoparticles-Induced Oxidative Stress Damage in the Liver of Young Rats.

Authors:  Penghui Nie; Mengqi Wang; Yu Zhao; Shanji Liu; Ling Chen; Hengyi Xu
Journal:  Nanomaterials (Basel)       Date:  2021-03-21       Impact factor: 5.076

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.